Patents matching “treatment”

US 6811782

Peptide composition as immunogen for the treatment of allergy

United Biomedical, Inc. · Granted Nov 2, 2004 · Expires Oct 28, 2024

US 6811775

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Nov 2, 2004 · Expires Oct 28, 2024

US 6809077

Cyclosporin analogs for the treatment of autoimmune diseases

Enanta Pharmaceuticals, Inc. · Granted Oct 26, 2004 · Expires Oct 21, 2024

US 6808702

Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs

The Board of Regents of the University of Texas System · Granted Oct 26, 2004 · Expires Oct 21, 2024

US 6806354

Methods and compositions for inducing autoimmunity in the treatment of cancers

The Board of Regents of the University of Texas System · Granted Oct 19, 2004 · Expires Oct 14, 2024

US 6803386

Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer

United Therapeutics Corporation · Granted Oct 12, 2004 · Expires Oct 7, 2024

US 6790980

Tannate compositions and methods of treatment

First Horizon Pharmaceutical Corporation · Granted Sep 14, 2004 · Expires Sep 9, 2024

US 6784156

Cyclosporins for the treatment of respiratory diseases

Enanta Pharmaceuticals, Inc. · Granted Aug 31, 2004 · Expires Aug 26, 2024

US 6783760

Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

The Board of Regents of the University of Texas System · Granted Aug 31, 2004 · Expires Aug 26, 2024

US 6780413

Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 24, 2004 · Expires Aug 19, 2024

US 6780995

Activated iododerivatives for the treatment of cancer and aids

Isotechnika, Inc. · Granted Aug 24, 2004 · Expires Aug 19, 2024

US 6770624

Treatment of heart failure with growth hormone

The Regents of the University of California · Granted Aug 3, 2004 · Expires Jul 29, 2024

US 6764681

Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 20, 2004 · Expires Jul 15, 2024

US 6759044

Cryptopain antibodies for prophylaxis, treatment, diagnosis and detection of Cryptosporidium species

The Regents of the University of California · Granted Jul 6, 2004 · Expires Jul 1, 2024

US 6749853

Combined methods and compositions for coagulation and tumor treatment

The Board of Regents of the University of Texas System · Granted Jun 15, 2004 · Expires Jun 10, 2024

US 6740638

Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein

Neurocrine Biosciences, Inc. · Granted May 25, 2004 · Expires May 20, 2024

US 6730692

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. · Granted May 4, 2004 · Expires Apr 29, 2024

US 6719969

Treatment of liver disease and injury with CXC chemokines

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 13, 2004 · Expires Apr 8, 2024

US 6713056

Combined preparation for the treatment of neoplasic diseases or of infectious diseases

I.D.M. Immuno-Designed Molecules · Granted Mar 30, 2004 · Expires Mar 25, 2024

US 6706686

Inhibition of histone deacetylase as a treatment for cardiac hypertrophy

The Regents of the University of Colorado · Granted Mar 16, 2004 · Expires Mar 11, 2024

US 6703050

Methods and compositions for the prevention or treatment of cancer

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 9, 2004 · Expires Mar 4, 2024

US 6699842

Dominant negative deletion mutants of C-jun and their use in the prevention and treatment of cancer

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 2, 2004 · Expires Feb 26, 2024

US 6696407

Huntington's disease treatment comprising administering aldose reductase inhibitors to increase striatal CNTF

The Regents of the University of California · Granted Feb 24, 2004 · Expires Feb 19, 2024

US 6692741

Treatment of acute lung injury and fibrosis with antagonists of &bgr;6-specific antibodies

The Regents of the University of California · Granted Feb 17, 2004 · Expires Feb 12, 2024